Prokidney (PROK) Free Cash Flow (2021 - 2026)
Prokidney's (PROK) quarterly Free Cash Flow came in at -$45.5 million in Q1 2026, down 47.98% year-on-year from -$87.4 million in Q1 2025, and down 18.83% on a QoQ basis from -$38.3 million in Q4 2025.
Prokidney (PROK) Free Cash Flow (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Free Cash Flow data on file, last reported at -$45.5 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 47.98% year-over-year to -$45.5 million in Q1 2026; TTM through Mar 2026 was -$150.1 million, a 0.61% increase from a year earlier, with the FY2025 full-year figure at -$135.3 million, up 13.18% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$45.5 million, down from -$38.3 million in the prior quarter.
- Over the last five years, Free Cash Flow for PROK reached as high as -$16.1 million in Q4 2022 and fell as low as -$51.7 million in Q3 2023.
- Historically, Free Cash Flow has averaged -$31.8 million across 5 years, with a median of -$31.6 million in 2024.
- Across the five-year window, Free Cash Flow sank 117921.88% in 2022 and surged 38.81% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$16.1 million in 2022, then tumbled by 67.77% to -$27.0 million in 2023, then plunged by 84.3% to -$49.7 million in 2024, then advanced by 22.98% to -$38.3 million in 2025, then decreased by 18.83% to -$45.5 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$45.5 million in Q1 2026, -$38.3 million in Q4 2025, and -$31.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -45.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.47 Mn |
| Mar 31, 2026 | -45.47 Mn |
| Dec 31, 2025 | -38.27 Mn |
| Dec 31, 2025 | -38.27 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Sep 30, 2025 | -31.79 Mn |
| Jun 30, 2025 | -34.53 Mn |
| Jun 30, 2025 | -34.53 Mn |
| Mar 31, 2025 | -30.73 Mn |
| Mar 31, 2025 | -30.73 Mn |
| Dec 31, 2024 | -49.68 Mn |
| Dec 31, 2024 | -49.68 Mn |
| Sep 30, 2024 | -31.65 Mn |
| Sep 30, 2024 | -31.65 Mn |
| Jun 30, 2024 | -38.93 Mn |
| Jun 30, 2024 | -38.93 Mn |
| Mar 31, 2024 | -35.61 Mn |
| Mar 31, 2024 | -35.61 Mn |
| Dec 31, 2023 | -26.96 Mn |
| Dec 31, 2023 | -26.96 Mn |